AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
Analyst coverage unavailable
Fundamentals
Fundamentals institutional score is 76 using growth durability 76.4.
Valuation
Valuation institutional score is 74 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
No usable analyst target or recommendation data was available.
Technical Structure
Technicals institutional score is 66 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
This data source has not been supplied for the decision payload.
Signal Summary
Market intelligence remains Neutral. fundamentals and valuation provide support.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 7.9% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -0.55). Confidence: 84%.
Live forward EPS implies next-12-month EPS of ₹19.32. Applying the stock's normalized valuation corridor produces a fair range of ₹238.80 to ₹295.40, with base value near ₹267.78 (+25.0% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹19.32
Forward P/E
11.1x
Base Fair Value
₹267.78
Fair Range
₹238.80 - ₹295.40
Upside To Base
+25.0%
Estimate Source
Live forward EPS
Growth Estimate
+24.3%
5Y Average
12.93
Current
12.76
Overvalued
15.29
Undervalued
12.36
5Y Average
7.10
Current
7.00
Overvalued
7.84
Undervalued
6.30
5Y Average
1.09
Current
1.05
Overvalued
1.25
Undervalued
0.92
Peers & Comparison
Sector: Materials · Theme: Specialty Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
ADVANCE AGROLIFE LIMITED ADVANCESpecialty Chemicals | +96.0% | 6.1% | 18.8x Undervalued | -56% vs avg | +11.9% |
AARTI SURFACTANTS LIMITED AARTISURFSpecialty Chemicals | +26.4% | 2.0% | 26.3x Undervalued | -39% vs avg | +10.8% |
AMBICA AGAR & AROMAINDLTD AMBICAAGARSpecialty Chemicals | -28.3% | 2.4% | 12.3x Undervalued | -71% vs avg | -9.6% |
AKSHARCHEM INDIA LIMITED AKSHARCHEMSpecialty Chemicals | +16.6% | -0.1% | — | — | -2.1% |
ADVANCED ENZYME TECH LTD ADVENZYMESSpecialty Chemicals | +21.6% | 22.6% | 19.8x Undervalued | -54% vs avg | -1.8% |
AETHER INDUSTRIES LIMITED AETHERSpecialty Chemicals | +27.5% | 19.1% | 92.2x Premium | +115% vs avg | +117.2% |
ANUPAM RASAYAN INDIA LTD ANURASSpecialty Chemicals | +27.5% | 7.2% | 78.3x Premium | +83% vs avg | +6.9% |
NAVIN FLUORINE INT. LTD NAVINFLUORSpecialty Chemicals | +44.1% | 21.7% | 52.9x Premium | +23% vs avg | +67.4% |
Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹354 CrJun 2026Latest net profit
₹20 CrJun 2026Latest EPS
₹6.54Jun 2026Net margin
9.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 245 | 257 | 231 | 271 | 314 | 294 | 305 | 295 | 331 | 254 | 242 | 316 | 354 |
| Expenses + | 231 | 237 | 216 | 250 | 290 | 269 | 280 | 273 | 305 | 233 | 224 | 287 | 323 |
| Operating Profit | 14 | 20 | 15 | 21 | 25 | 25 | 26 | 22 | 26 | 21 | 18 | 29 | 32 |
| OPM % | 6% | 8% | 7% | 8% | 8% | 9% | 8% | 7% | 8% | 8% | 7% | 9% | 9% |
| Other Income + | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 3 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 11 | 17 | 12 | 18 | 21 | 21 | 21 | 17 | 22 | 16 | 14 | 26 | 26 |
| Tax % | 26% | 26% | 25% | 31% | 26% | 27% | 26% | 23% | 25% | 24% | 28% | 25% | 25% |
| Net Profit + | 8 | 12 | 9 | 12 | 15 | 15 | 16 | 13 | 16 | 12 | 10 | 19 | 20 |
| EPS in Rs | 2.74 | 4.15 | 3.05 | 4.13 | 5.08 | 5.06 | 5.22 | 4.48 | 5.41 | 4.11 | 3.35 | 6.46 | 6.54 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).